New antiviral drugs for the treatment of the common cold

Autor: Maugeri C., Alisi M.A., Apicella C., Cellai L., Dragone P., Fioravanzo E., Florio S., Furlotti G., Mangano G., Ombrato R., Luisi R., Pompei R., Rinciotti V., Russo V., Vitiello M., Cazzolla N.

Publikováno v: Bioorganic & medicinal chemistry
16 (2008): 3091–3107.
info:cnr-pdr/source/autori:Maugeri C., Alisi M.A., Apicella C., Cellai L., Dragone P., Fioravanzo E., Florio S., Furlotti G., Mangano G., Ombrato R., Luisi R., Pompei R., Rinciotti V., Russo V., Vitiello M., Cazzolla N./titolo:New antiviral drugs for the treatment of the common cold/doi:/rivista:Bioorganic & medicinal chemistry (Print)/anno:2008/pagina_da:3091/pagina_a:3107/intervallo_pagine:3091–3107/volume:16

—Human Rhinovirus (HRV) is the most important aetiologic agent of common cold in adults and children. HRV is a single- stranded, positive sense RNA virus and, despite the high level of conservation among different serotypes, sequence alignment of vi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::7774a6d6492e06969fdc5c2786e414d2
https://publications.cnr.it/doc/19786